By Day-25 nearly all the CD8+ T-cells and the majority of CD4+ effector T-cells infiltrating the B16 melanoma tumors of α4-1BB and α4-1BB/αCTLA-4 treated mice are KLRG1+ (Figure 6A and B). Here, KLRG1 is linked to melanoma.